Press "esc" to clear
Go to Advanced Search

Showing results

110 of 83
Embargo will expire:
17-Dec-2018 11:00 AM EST
Released to reporters:
13-Dec-2018 11:05 AM EST


A reporter's PressPass is required to access this story until the embargo expires on 17-Dec-2018 11:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 705292

The Weizmann Institute of Science Establishes the Dr. Barry Sherman Institute for Medicinal Chemistry

Weizmann Institute of Science

The new Sherman Institute will advance basic research on novel therapies for a range of disorders, including autoimmune, neurodegenerative, and infectious diseases, as well as cancer.

11-Dec-2018 5:05 PM EST

Article ID: 705110

The Richer the Reward, The Faster You’ll Likely Move to Reach It, Study Shows

Johns Hopkins Medicine

If you are wondering how long you personally are willing to stand in line to buy that hot new holiday gift, scientists at Johns Hopkins Medicine say the answer may be found in the biological rules governing how animals typically forage for food and other rewards.

11-Dec-2018 8:00 AM EST

Article ID: 705180

Two Compounds in Coffee May Team Up to Fight Parkinson’s

Rutgers University-New Brunswick

Rutgers scientists have found a compound in coffee that may team up with caffeine to fight Parkinson’s disease and Lewy body dementia – two progressive and currently incurable diseases associated with brain degeneration.

10-Dec-2018 12:05 PM EST
  • Embargo expired:
    5-Dec-2018 6:00 AM EST

Article ID: 704924

A toxin that travels from stomach to brain may trigger Parkinsonism

Penn State College of Medicine

Combining low doses of a toxic herbicide with sugar-binding proteins called lectins may trigger Parkinsonism -- including symptoms like body tremors and slowing of body motions -- after the toxin travels from the stomach to the brain.

4-Dec-2018 4:05 PM EST

Article ID: 704716

PhRMA Foundation Releases Highlights of its 2018 Funding Efforts

PhRMA Foundation

The PhRMA Foundation awarded more than $6 million over the last two years to more than 100 leaders in scientific research in the United States. The Foundation is proud to announce another successful year supporting innovative research efforts in areas of great importance: Alzheimer’s Disease, Melanoma, Parkinson’s Disease, Schizophrenia, Breast Cancer, Lung Cancer, Leukemia, Ulcerative Colitis, Vascular Disease, and Colorectal Cancer. This year the Foundation also funded two Centers of Excellence in Value Assessment.

30-Nov-2018 2:05 PM EST

Article ID: 704698

Many diseases increase the risks of hip fracture surgery

University of Eastern Finland

Parkinson's disease, osteoarthritis, rheumatic diseases, alcoholism and mental health disorders increase the risk of surgical complications after a hip fracture surgery, a new Finnish study analysing nationwide registers finds. 4.6% of all hip surgery patients and 10% of total hip replacement surgery patients experienced surgical complications within three months following their surgery.

30-Nov-2018 12:05 PM EST
  • Embargo expired:
    21-Nov-2018 4:00 PM EST

Article ID: 704247

Orange Juice, Leafy Greens and Berries May Be Tied to Decreased Memory Loss in Men

American Academy of Neurology (AAN)

Eating leafy greens, dark orange and red vegetables and berry fruits, and drinking orange juice may be associated with a lower risk of memory loss over time in men, according to a study published in the November 21, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

19-Nov-2018 5:05 PM EST
  • Embargo expired:
    14-Nov-2018 12:05 AM EST

Article ID: 702925

Researchers Find Inhibiting One Protein Destroys Toxic Clumps Seen in Parkinson’s Disease

Georgetown University Medical Center

A team of neurologists at Georgetown University Medical Center has found that inhibiting the USP13 molecule may be a therapeutic target in Parkinson’s disease and other similar forms of neurodegeneration.

9-Nov-2018 7:05 AM EST

Showing results

110 of 83

Chat now!